Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Test predicts outcome of hay fever therapies

18.10.2018

Allergen-specific immunotherapy can make everyday life much more pleasant for allergy sufferers and provide long-term protection against asthma. It is unclear, however, what exactly happens during this treatment. A team at the Technical University of Munich (TUM) and Helmholtz Zentrum München investigated the processes taking place in the body over the course of a three-year allergen-specific immunotherapy. The researchers found clues as to why the allergy immunization takes so long and how the chances of success can be determined at a very early stage.

In allergen-specific immunotherapy – once known as hyposensitization – doctors inject patients with the substances that cause allergic reactions, mostly pollen or mite allergen extracts. In the first phase of the therapy, the dose is gradually increased.


Once a so-called maintenance dose is reached, the patient receives injections at that dosage over an extended period – generally three years. If all goes well, there is lasting reduction in the intensity of allergic reactions after the treatment is completed.

It is still unclear what exactly happens in the body during these treatments. A team surrounding Dr. Adam Chaker, the head of the Allergy Outpatient Clinic at the Clinic and Polyclinic for Ear, Nose and Throat Medicine at the the TUM rechts der Isar University Hospital and Professor Carsten Schmidt-Weber, head of the Center for Allergies and the Environment (ZAUM) of TUM and the Helmholtz Zentrum München, has now completed the first investigation of the complex interplay of various cell types and substances of the human immune system over the course of a three-year immunotherapy treatment.

Many different immune cells involved

In the past, allergy research has focused particularly on the role of various types of T cells.According to this – albeit highly simplified – model, pro-allergic T cells (Th2 and Th17 cells) heighten the allergic responses in the body when they encounter certain substances. Regulatory T cells (T regs), by contrast, inhibit the response to an allergen.

“Our data show that the bodily processes during immunotherapy are far more complex than once believed," says Adam Chaker. "They involve cell types that have previously received very little attention in this context. In particular, we are convinced that regulatory B cells play a much more important role than we once thought.”

Test shows: the second therapy phase is not a game of chance

“In the second treatment phase, the body's immune system decides whether to continue launching all-out attacks on an allergen, resulting in hay fever, asthma or other allergic conditions, or whether the body will learn to tolerate the allergen,” explains Adam Chaker.

The ratios of pro-allergic T cells, T regs and regulatory B-cells undergo constant change during that time. Over the course of the study, there were repeated shifts in which of the cell types was most numerous, also depending on pollen counts and other factors, with different types more prevalent at various times. It was only after around three years that the ratios gradually stabilized.

However, this phase is anything but a game of chance. In the patients who completed the treatment as planned, there were common factors that made it possible to forecast the success of the therapy at an early stage. If a lot more regulatory B-cells and a lot fewer TH-17 cells are counted immediately after the first phase, i.e. the introductory treatment phase, a significant decrease in allergy symptoms was seen after three years.

Good reasons for seeing the treatment through

“We have patented this test,” says Adam Chaker. “If we can develop it to the point where it can go into full production, we could save patients from going through expensive and time-consuming treatments with little chance of success. But in case of a positive test result, there are good reasons for seeing a three-year therapy through to the end. In the past, people have tended to give up before finishing.”

In addition, a better understanding of the molecular mechanisms could serve as the basis for more effective treatments. To do that, however, it will be necessary to confirm the results of the current study through additional investigations and find out more about the mechanisms involved, says Adam Chaker.

Wissenschaftliche Ansprechpartner:

PD Dr. Adam M. Chaker
Technische Universität München
Klinikum rechts der Isar
Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde und
Zentrum für Allergie und Umwelt (ZAUM)
Tel: +49 89 4140 2370
adam.chaker@tum.de

Originalpublikation:

U.M. Zissler, C.A. Jakwerth, F.M. Guerth, L. Pechtold, J.A. Aguilar-Pimentel, K. Dietz, K. Suttner, G. Piontek, B. Haller, Z. Hajdu, M. Schiemann, C.B. Schmidt-Weber, A.M. Chaker. Early IL-10 producing B-cells and coinciding Th/Tr17 shifts during three year grass-pollen AIT. EBioMedicine (2018) DOI:https://doi.org/10.1016/j.ebiom.2018.09.016

Weitere Informationen:

https://www.zaum-online.de Zentrum Allergie und Umwelt (ZAUM):
http://www.hno.mri.tum.de Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde

Dr. Ulrich Marsch | Technische Universität München

More articles from Life Sciences:

nachricht Phage capsid against influenza: Perfectly fitting inhibitor prevents viral infection
31.03.2020 | Forschungsverbund Berlin

nachricht A 'cardiac patch with bioink' developed to repair heart
31.03.2020 | Pohang University of Science & Technology (POSTECH)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Physicist from Hannover Develops New Photon Source for Tap-proof Communication

An international team with the participation of Prof. Dr. Michael Kues from the Cluster of Excellence PhoenixD at Leibniz University Hannover has developed a new method for generating quantum-entangled photons in a spectral range of light that was previously inaccessible. The discovery can make the encryption of satellite-based communications much more secure in the future.

A 15-member research team from the UK, Germany and Japan has developed a new method for generating and detecting quantum-entangled photons at a wavelength of...

Im Focus: Junior scientists at the University of Rostock invent a funnel for light

Together with their colleagues from the University of Würzburg, physicists from the group of Professor Alexander Szameit at the University of Rostock have devised a “funnel” for photons. Their discovery was recently published in the renowned journal Science and holds great promise for novel ultra-sensitive detectors as well as innovative applications in telecommunications and information processing.

The quantum-optical properties of light and its interaction with matter has fascinated the Rostock professor Alexander Szameit since College.

Im Focus: Stem Cells and Nerves Interact in Tissue Regeneration and Cancer Progression

Researchers at the University of Zurich show that different stem cell populations are innervated in distinct ways. Innervation may therefore be crucial for proper tissue regeneration. They also demonstrate that cancer stem cells likewise establish contacts with nerves. Targeting tumour innervation could thus lead to new cancer therapies.

Stem cells can generate a variety of specific tissues and are increasingly used for clinical applications such as the replacement of bone or cartilage....

Im Focus: Artificial solid fog material creates pleasant laser light

An international research team led by Kiel University develops an extremely porous material made of "white graphene" for new laser light applications

With a porosity of 99.99 %, it consists practically only of air, making it one of the lightest materials in the world: Aerobornitride is the name of the...

Im Focus: Cross-technology communication in the Internet of Things significantly simplified

Researchers at Graz University of Technology have developed a framework by which wireless devices with different radio technologies will be able to communicate directly with each other.

Whether networked vehicles that warn of traffic jams in real time, household appliances that can be operated remotely, "wearables" that monitor physical...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“4th Hybrid Materials and Structures 2020” takes place over the internet

26.03.2020 | Event News

Most significant international Learning Analytics conference will take place – fully online

23.03.2020 | Event News

MOC2020: Fraunhofer IOF organises international micro-optics conference in Jena

03.03.2020 | Event News

 
Latest News

Phage capsid against influenza: Perfectly fitting inhibitor prevents viral infection

31.03.2020 | Life Sciences

A 'cardiac patch with bioink' developed to repair heart

31.03.2020 | Life Sciences

Artificial intelligence can speed up the detection of stroke

31.03.2020 | Medical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>